Arianna Ferrari Christopher Coenen Armin Grunwald Arnold Sauter ...

Parens, E. (ed.) (1998): Enhancing human traits: ethical and social implications.
Washington, D.C.: Georgetown University Press.
Paris M.C., Zhao R., West J.A. et al. (2007): A perspective on the role of emer-
ging technologies for the propagation of companion animals, non-domestic and
endangered species, Reproduction Fertility Development 19(6): III–VII.
Park I.-H. et al. (2008): Reprogramming of human somatic cells to pluripotency
with defined factors, Nature 451: 141–147.
Park K.I., Himes B.T., Stieg P.E. et al. (2006): Neural stem cells may be uni-
quely suited for combined gene therapy and cell replacement: Evidence from
engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain
injury, Experimental Neurology 199(1): 179–190.
Paschen, H., Coenen, C., Fleischer, T., Grünwald, R., Oertel, D., Revermann,
C. (2004): Nanotechnologie. Forschung, Entwicklung, Anwendung. Springer:
Berlin, Heidelberg.
PCB (US President’s Council on Bioethics) (2003): Beyond Therapy.
US President’s Council on Bioethics: Washington.
Pedrono E., Durukan A., Strbian D. et al. (2010): An Optimized Mouse Model
for Transient Ischemic Attack, Journal of Neuropathological Experimental
Neurology 69(2): 188–95.
Peng S., Garzon D.J., Marchese M. et al. (2009): Decreased brain-derived
neurotrophic factor depends on amyloid aggregation state in transgenic mouse
models of Alzheimer’s disease, Journal of Neuroscience 29(29): 9321–9.
Pereira S., Tettamanti M. (2005): Ahimsa and alternatives – the concept of the
4th R. The CPCSEA in India, ALTEX 1: 3–6
Perler D., Wild M. (Hg.): Der Geist der Tiere. Suhrkamp: Stuttgart.
Petermann T., Sauter, A. (1999): Xenotransplantation – Sachstandsbericht
(TAB-Arbeitsbericht Nr. 64), Berlin: Büro für Technikfolgen-Abschätzung
beim Deutschen Bundestag.
Peterson M.E. (1999): Medical treatment of pituitary-dependent hyperadre-
nocorticism in dogs: should L-deprenyl (Anipryl) ever be used?, Journal of
Veterinary Internal Medicine 13(4): 289–90.
Peterson M.E. (2001): Medical treatment of canine pituitary-dependent
hyperadrenocorticism (Cushing’s disease),
Vet Clin North Am Small Anim Pract. 31(5): 1005–14, VIII.
Pierson R.N. et al. (1989): Xenogenic skin graft rejection is especially depen-
dent on CD4+ T cells, Journal of Experimental Medicine 170(3): 991–996.
Pierson R.N. (2009): Current status of xenotransplantation,
JAMA 301(9): 967–9.
Piña-Aguilar R.E., Lopez-Saucedo J., Sheffield R. et al. (2009): Revival of
extinct species using nuclear transfer: hope for the mammoth, true for the
Pyrenean ibex, but is it time for «conservation cloning»?,
Cloning Stem Cells 11(3): 341–6.
Pinkert C.A., Galbreath E.J., Yang C.W., Striker L.J. (1994): Liver, renal and
subcutaneous histopathology in PEPCK-bGH transgenic pigs,
Transgenic Research 3: 401–405.
Pitkanen T.I., Krasnov A., Teerijoki H., Moelsae H. (1999): Transfer of growth
hormone (GH) transgenes into Arctic charr (Salvelinus alpinus L.) I. Growth
response to various GH constructs,
Genetic Analysis of Biomolecular Engineering 15:91–98.
Pluhar E. (1985): On the genetic manipulation of animals,
Between the species 1: 13–18.
Pluhar E. (1986): The moral justifiability of genetic manipulation,
Between the species 2: 136–138.
Poncelet A.J., Denis D., Gianello P. (2009): Cellular Xenotransplantation,
Current Opinion in Organ Transplantation 14(2): 168–174.
Pöppinghege R. (Hg.) (2009):
Tiere im Krieg. Von der Antike bis zur Gegenwart. Schoeningh: Paderborn.
210 Animal Enhancement | Beiträge zur Ethik und Biotechnologie Animal Enhancement | Beiträge zur Ethik und Biotechnologie
211